Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volttm PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results